Read More 2 minute read FFinance Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This WeekbytadyJune 20, 2025 Shares in Verve Therapeutics (NASDAQ: VERV) soared 80.5% this week on the news of an agreement for Eli…